No evidence for germline PTEN mutations in families with breast and brain tumours

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 216-219

  Laugé, Anthony ^a   Lefebvre, Céline ^a   Laurent Puig, Pierre ^b   Caux, Virginie ^a   Gad, Sophie ^a   Eng, Charis ^c,d   Longy, Michel ^e   Stoppa Lyonnet, Dominique ^a  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INSTITUT BERGONIÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COWDEN SYNDROME; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; MENINGIOMA; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL;

BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GERM-LINE MUTATION; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0033060408     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<216::AID-IJC3>3.0.CO;2-E     Document Type: Article

References (25)

1. CAIRNS, P., OKAMI, K., HALACHMI, S., HALACHMI, N., ESTELLET, M., HERMAN, J.G., JEN, J., ISAACS, W.B., BOVA, G.S. and SIDRANSKY, D., Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
2. DAHIA, P.L.M., MARSH, D.J., ZHENG, Z., ZEDENIUS, J., KOMMINOTH. P., FRISK, T., WALLIN, G., PARSONS, R., LONGY, M., LARSSON, C. and ENG, C., Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumours. Cancer Res., 57, 4710-4713 (1997).
3. DÜRR, E.M., ROLLBROCKER, B., HAYASHI, Y., PETERS, N., MEYER-PUTTLIZ, B., LOUIS, D.N., SCHRAMM, J., WIESLER, O.D., PARSONS, R., ENG, C. and von DEIMLING, A., PTEN mutations in gliomas and glioneuronal tumours. Oncogene, 16, 2259-2264 (1998).
4. ENG, C., Cowden disease. J. genet. Counsel., 6, 181-191 (1997).
5. FORD, D. and 38 OTHERS, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Amer. J. hum. Genet., 62, 676-689 (1998).
6. GROMPE, M., The rapid detection of unknown mutations in nucleic acids Nature (Genet.), 5, 111-117 (1993).
7. HABER, D. and HARLOW, E., Tumour suppressor genes: evolving definitions in the genomic age. Nature (Genet.), 16, 320-322 (1997).
8. KONG, D. and 18 OTHERS, PTEN is frequently mutated in primary endometrial carcinomas. Nature (Genet.), 17, 143-144 (1997).
9. LI, D.M. and SUN, H., TEP1, encoded by a candidate tumour suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57, 2124-2129 (1997).
10. LI, J. and 16 OTHERS, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
11. LIAW, D., MARCH, D.J., LI, J., DAHIA, P.L.M., WANG, S.I., ZHENG, Z., BOSE, S., CALL, K.M., TSOU, H.C., PEACOKE, M., ENG, C. and PARSONS, R., Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature (Genet.), 16, 64-67 (1997).
12. LYNCH, E.D. and 14 OTHERS, Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Amer. J. hum. Genet., 61, 1254-1260 (1997).
13. MARSH, D.J., DAHIA, P.L.M., CARON, S., KUM, J.B., FRAYLING, I.M., TOMLINSON, I.P.M., HUGHES, K.S., HODGSON, S.V., MURDAY, V.A., HOULSTON, R., and E NG, C., Germline PTEN mutations in Cowden syndrome-like families. J. Med. Genet., 35, 881-885 (1998a).
14. MARSH, D.J. and 15 OTHERS, Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Gene Chromosomes Cancer, 21, 61-69 (1998b).
15. MARSH, D.J., DAHIA, P.L.M., ZHENG, Z., LIAW, D., PARSONS, R., GORLIN, R.J. and ENG, C., Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature (Genet.), 16, 333-334 (1997).
16. MYERS, M.P., STOLAROV, J., ENG, C., LI, J., WANG, S.I., WIGLES, M.H., PARSONS, R. and TONKS, N.K, PTEN, the tumor suppressor gene from human chromosome 10q23, is a dual specificity phosphatase. Proc. natl. Acad. Sci. (Wash.), 94, 9052-9057 (1997).
17. PETERS, N., and 12 OTHERS, Analysis of the PTEN gene in human meningiomas. Neuropathol. appl. Neurobiol., 24, 3-8 (1998).
18. REMPEL, S.A., SCHWECHEIMER, K., DAVIS, R.L., CAVENEE, W.K. and ROSENBLUM, M.L., Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res., 53(Suppl. 10), 2386-2392 (1993).
19. RHEI, E., KANG, L., BOGOMOLNYI, F., FERECI, M.G., BORGEN, P.I. and BOYD, J., Mutation analysis of the putative tumour suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res., 57, 3657-3659 (1997).
20. SIMON, M., von DEIMLING, A., LARSON, J.J., WELLEHENREUTHER, R., KASKEL, P., WAHA, A., WARNICK, R.E., TEW, J.M. Jr. and MENON, A.G., Allelic losses on chromosome 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of menigioma progression. Cancer Res., 55, 4696-4701 (1995).
21. STECK, P.A. and 13 OTHERS, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature (Genet.), 15, 356-362 (1997).
22. STOPPA-LYONNET, D., LAURENT-PUIG, P., ESSIOUX, L., PAGES, S., ITHIER, G., LIGOT, L., FOURQUET, A., SALMON, R.J., CLOUGH, K.B., POUILLART, P., the Institut Curie Breast Cancer Group, BONAITI-PELLIÉ, C. and THOMAS, G., BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Amer. J. hum. Genet., 60, 1021-1030 (1997).
23. TAMUR, A.M., GU, J., MATSUMOTO, K., AOTA, S.I., PARSONS, R. and YAMADA, K.M., Inhibition of cell migration, spreading and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617 (1998).
24. TSOU, H.C. and 14 OTHERS, The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Amer. J. hum. Genet., 61, 1036-1043 (1997).
25. VARLEY, J.M., EVANS, D.G.R. and BICH, J.M., Li-Fraumeni syndrome: a molecular and clinical review. Brit. J. Cancer, 76, 1-14 (1997).